258 related articles for article (PubMed ID: 31410600)
1. Guideline adherence in bone-targeted treatment of cancer patients with bone metastases in Germany.
Link H; Diel I; Ohlmann CH; Holtmann L; Kerkmann M;
Support Care Cancer; 2020 May; 28(5):2175-2184. PubMed ID: 31410600
[TBL] [Abstract][Full Text] [Related]
2. Real-world use of denosumab and bisphosphonates in patients with solid tumours and bone metastases in Germany.
Diel I; Ansorge S; Hohmann D; Giannopoulou C; Niepel D; Intorcia M
Support Care Cancer; 2020 Nov; 28(11):5223-5233. PubMed ID: 32086567
[TBL] [Abstract][Full Text] [Related]
3. G-CSF guideline adherence in Germany, an update with a retrospective and representative sample survey.
Link H; Kerkmann M; Holtmann L; Ortner P;
Support Care Cancer; 2019 Apr; 27(4):1459-1469. PubMed ID: 30374765
[TBL] [Abstract][Full Text] [Related]
4. Initiation of bone-targeted agents in patients with bone metastases and breast or castrate-resistant prostate cancer actively treated in routine clinical practice in Europe.
von Moos R; Lewis K; Massey L; Marongiu A; Rider A; Seesaghur A
Bone; 2022 Jan; 154():116243. PubMed ID: 34757213
[TBL] [Abstract][Full Text] [Related]
5. Bone health and adherence to vitamin D and calcium therapy in early breast cancer patients on endocrine therapy with aromatase inhibitors.
Bošković L; Gašparić M; Petković M; Gugić D; Lovasić IB; Soldić Ž; Miše BP; Dabelić N; Vazdar L; Vrdoljak E
Breast; 2017 Feb; 31():16-19. PubMed ID: 27810693
[TBL] [Abstract][Full Text] [Related]
6. Practice patterns and guideline adherence of medical oncologists in managing patients with early breast cancer.
Foster JA; Abdolrasulnia M; Doroodchi H; McClure J; Casebeer L
J Natl Compr Canc Netw; 2009 Jul; 7(7):697-706. PubMed ID: 19635225
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Guideline Adherence in Colorectal Cancer Treatment in The Netherlands: A Survey Among Medical Oncologists by the Dutch Colorectal Cancer Group.
Keikes L; van Oijen MGH; Lemmens VEPP; Koopman M; Punt CJA
Clin Colorectal Cancer; 2018 Mar; 17(1):58-64. PubMed ID: 29157662
[TBL] [Abstract][Full Text] [Related]
8. Association of Behavioral Nudges With High-Value Evidence-Based Prescribing in Oncology.
Takvorian SU; Ladage VP; Wileyto EP; Mace DS; Beidas RS; Shulman LN; Bekelman JE
JAMA Oncol; 2020 Jul; 6(7):1104-1106. PubMed ID: 32352478
[TBL] [Abstract][Full Text] [Related]
9. Treatment dynamics of bone-targeting agents among men with bone metastases from prostate cancer in the United States.
Butler AM; Cetin K; Hernandez RK; Diane Reams B; Overman RA; I Kim J; Hirsch BR; Abernethy AP; Liede A; Alan Brookhart M
Pharmacoepidemiol Drug Saf; 2018 Feb; 27(2):229-238. PubMed ID: 29316026
[TBL] [Abstract][Full Text] [Related]
10. [Osteoprotection in patients with bone metastatic castration-resistant prostate cancer (mCRPC): real-world data from Germany, presented by d-uo].
Doehn C; Klier J; Johannsen M; Eichenauer R; Schönfelder R; Romagnolo A; Reese S; Nitz C; Jaeger A; Fieseler C; Burkert-Scholz M; Brenneis H; Binder M; Beuke M; Schröder J; Hempel E; König F
Aktuelle Urol; 2022 Dec; 53(6):526-534. PubMed ID: 36423613
[TBL] [Abstract][Full Text] [Related]
11. Effect of denosumab versus zoledronic acid on calcium levels in cancer patients with bone metastasis: A retrospective cohort study.
Nasser SM; Sahal A; Hamad A; Elazzazy S
J Oncol Pharm Pract; 2019 Dec; 25(8):1846-1852. PubMed ID: 31694497
[TBL] [Abstract][Full Text] [Related]
12. Adherence to granulocyte-colony stimulating factor (G-CSF) guidelines to reduce the incidence of febrile neutropenia after chemotherapy--a representative sample survey in Germany.
Link H; Nietsch J; Kerkmann M; Ortner P;
Support Care Cancer; 2016 Jan; 24(1):367-376. PubMed ID: 26081593
[TBL] [Abstract][Full Text] [Related]
13. Which bisphosphonates do oncologists prescribe for women with metastatic breast cancer and why? Results of a UK survey.
Fallowfield L; Jenkins V; Coleman R
Breast; 2008 Oct; 17(5):459-63. PubMed ID: 18455921
[TBL] [Abstract][Full Text] [Related]
14. [Home-based zoledronic acid infusion therapy in patients with solid tumours: compliance and patient-nurse satisfaction].
Lebret T; Mouysset JL; Lortholary A; Kouri CE; Bastit L; Ktiouet M; Khemaies S; Murraciole X; Guérif S
Bull Cancer; 2013 Mar; 100(3):247-57. PubMed ID: 23518272
[TBL] [Abstract][Full Text] [Related]
15. Medication adherence with denosumab in patients with bone metastases from solid tumors treated in routine clinical settings: a retrospective study.
Diel IJ; Greil R; Janssen J; Kluike CW; Behera B; Abbasi A; Seesaghur A; Kellner M; Jaeger C; Bjorklof K; Tomova A; Haslbauer F
Support Care Cancer; 2022 Nov; 30(11):9267-9278. PubMed ID: 36066628
[TBL] [Abstract][Full Text] [Related]
16. National survey of radiation oncologists' practice patterns regarding hormone-naïve prostate cancer with bone metastases.
Nakamura K; Ishikawa H; Akimoto T; Aoki M; Kariya S; Kawamura H; Kumano T; Kozuka T; Konishi K; Sakaguchi M; Takayama K;
Jpn J Clin Oncol; 2020 Sep; 50(10):1188-1194. PubMed ID: 32627817
[TBL] [Abstract][Full Text] [Related]
17. Therapies used in prostate cancer patients by European urologists: data on indication with a focus on expectations, perceived barriers and guideline compliance related to the use of bisphosphonates.
Heidenreich A; Witjes WP; Bjerklund-Johansen TE; Patel A;
Urol Int; 2012; 89(1):30-8. PubMed ID: 22699678
[TBL] [Abstract][Full Text] [Related]
18. The effects of denosumab on calcium profiles in advanced cancer patients with bone metastases.
Lechner B; DeAngelis C; Jamal N; Emmenegger U; Pulenzas N; Giotis A; Sheehan P; Tsao M; Bedard G; Chow E
Support Care Cancer; 2014 Jul; 22(7):1765-71. PubMed ID: 24515277
[TBL] [Abstract][Full Text] [Related]
19. An Observational Study of Concomitant Use of Emerging Therapies and Denosumab or Zoledronic Acid in Prostate Cancer.
Liede A; Wade S; Lethen J; Hernandez RK; Warner D; Abernethy AP; Finelli A
Clin Ther; 2018 Apr; 40(4):536-549.e3. PubMed ID: 29395290
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonate use for the management of breast cancer patients with bone metastases: a survey of Canadian Medical Oncologists.
Verma S; Kerr-Cresswell D; Dranitsaris G; Charbonneau F; Trudeau M; Yogendran G; Cesta AM; Clemons M
Support Care Cancer; 2004 Dec; 12(12):852-8. PubMed ID: 15322969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
